Observational Study
Copyright ©The Author(s) 2015.
World J Clin Pediatr. Aug 8, 2015; 4(3): 45-49
Published online Aug 8, 2015. doi: 10.5409/wjcp.v4.i3.45
Table 1 Clinical characteristics of neonates receiving levetiracetam
Patient 1Patient 2Patient 3Patient 4Patient 5Patient 6Patient 7Patient 8Patient 9Patient 10Patient 11Patient 12
Gestation (wk)3839353841293623 6/730393640
Apgar score (1 and 5 min)9, 109, 109, 109, 108, 107, 90, 04, 60, 00, 00, 04, 7
Age of seizure onset (days of life)19108110030000
EtiologyGBS meningitisHSV encephalitisSuspected mitochond-rialHypoglycemiaSulphite oxidase deficiencyE. Coli meningitisHIEHIEHIEHIEHIEHIE
NeuroimagingCystic encephalo-malaciaCystic encephalo-malaciaCystic encephalo-malaciaNormalCystic encephalo-malaciaHydrocephalus with generalized atrophyCystic encephalo-malaciaCystic encephalo-malaciaPeri-ventricular leukomalaciaNormalPeri-ventricular leukomalaciaDiffuse cystic encephalo-malcia
Electrographic seizuresYesYesYesYesYesYesYesYesYesYesYesYes
Clinical status epilepticusNoNoNoNoNoYesNoNoNoNoNoYes
Hypothermia------NoNoNoYesYesYes
Anticonvulsant orderPHB/MDZ/LEVPHB/LEVPHB/LEVPHB/LEVPHB/LEVPHB/MDZ/THI/LEVPHB/MDZ/LEVPHB/MDZ/LEVPHB/MDZ/LEVPHB/MDZ/LEVPHB/MDZ/LEVPHB/MDZ/LEV/THI
LEV loading dose (mg/kg)1520107.5101015161810820
Mm maintenance (mg/kg per day)27402060203036536201540
Seizure after 24 hNoNoNoNoNoYesYesNoYesYesNoYes
Seizure after 72 hNoNoNoNoNoNoNoNoYesYesNoYes
Anticonvulsant at dischargeLEVTPM/LEVPHB/LEVPHB/LEVNot applicableTPM/LEVNot applicableLEVLEV/TPMLEVPHB/LEVPHB/LEV
OutcomeMild delaySevere delaySevere delayNormalDeathSevere delayDeathSevere delayModerate delayMild delaySevere delaySevere delay
Table 2 Literature review of levetiracetam use in neonates
Ref.Year of publicationNo. of patientsDrugs used before LEVOutcome: SeizureNo. of patients with HIESeizure outcome in HIE patientsDosage (loading)(mg/kg)Dosage (maintenance) (mg/kg per day)Remarks
Shoemaker et al[4]20073PHB/MDZ/fPHTAll seizure free1Seizure controlled within 17 min of oral bolus60 (oral)30
Fürwentsches et al[5]20106PHBAll seizure free in 6 d1Seizure freeNA10-50Prospective
Ledet et al[6]20101PHBSeizure free0NANA40
Ramantani et al[7]201138NA30 seizure free at 1 wk9NA1045-60Prospective
Khan et al[8]201122PHB or PHT19 seizure cessation at 1 h and 22 seizure free by 72 h1211 seizure cessation at 1 h
Abend et al[9]201123PHB or PHT7 seizure terminated, 1 reduced seizure > 50%, 1 seizure terminated in > 24 h, 2 improvement in > 24 h, 8 no improvement, 1 unable to judge82 seizure terminated, 2 reduced seizures > 50%, 1 improvement in > 24 h, 2 no improvement, 1 unable to judge5-2210-80LEV as first drug in 4 cases
Aylward et al[10]20111fPHTPartially responsive0NA2019
Sharpe et al[11]201218PHB6 seizure controlled8NA20-405-10
Rakshasbhuvankar et al[12]20138PHB/PHT/MDZ6 "excellent", 1 partial, 1 ineffective54 "excellent", 1 "partial"5-1010-35
Khan et al[13]201312PHB9 seizure stopped in 24 h53 seizure stopped in 24 h, 1 no response, 1 NA25-5050
Kirmani[14]201412PHB10 seizure free by 72 h5NA25-5025-50